Recursion Pharmaceuticals, Inc. (RXRX)
3.78
+0.18
(+5.00%)
USD |
NASDAQ |
Apr 17, 16:00
3.78
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals SG&A Expense (Quarterly) : 33.66M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 33.08M |
| Tango Therapeutics, Inc. | 9.763M |
| KalVista Pharmaceuticals, Inc. | 61.00M |
| Geron Corp. | 41.67M |
| Ionis Pharmaceuticals, Inc. | 130.00M |